Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi Sankyo and Roche.

Commissions do not affect our editors' opinions or evaluations. The best no-fee checking account is Axos Bank Rewards Checking, which scored 4.8 stars (out of a possible 5) thanks to its ...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...